Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q15257
UPID:
PTPA_HUMAN
Alternative names:
PP2A, subunit B', PR53 isoform; Phosphotyrosyl phosphatase activator; Serine/threonine-protein phosphatase 2A regulatory subunit 4; Serine/threonine-protein phosphatase 2A regulatory subunit B'
Alternative UPACC:
Q15257; A2A347; A9IZU4; B4DXM4; Q15258; Q53GZ3; Q5TZQ2; Q9BUK1; Q9NNZ7; Q9NNZ8; Q9NNZ9
Background:
The Serine/threonine-protein phosphatase 2A activator, known by alternative names such as PP2A, subunit B', PR53 isoform, and Phosphotyrosyl phosphatase activator, plays a crucial role in protein folding through PPIases acceleration. It modulates the activity and substrate specificity of serine/threonine-protein phosphatase 2A (PP2A) by inducing conformational changes. This protein is also involved in reactivating inactive phosphatase PP2A-phosphatase methylesterase complexes and stimulating phosphotyrosyl phosphatase activity, which is essential for apoptosis regulation.
Therapeutic significance:
Understanding the role of Serine/threonine-protein phosphatase 2A activator could open doors to potential therapeutic strategies.